• 10 January 2019

    DMAb trial for Zika prevention gets FDA approval

    The Wistar Institute, Penn Medicine and Inovio Pharmaceuticals have announced the receipt of FDA approval for commencement of a first-in-human clinical trial to probe the safety and tolerability of a...

  • 9 October 2018

    September’s top news stories

    Emerald Health Pharmaceuticals (EHP) started patient enrolment for its Phase I clinical trial of EHP-101 for the treatment of patients with multiple sclerosis (MS) and scleroderma, and Ra Pharmaceuticals reported...

  • 4 May 2018

    April’s top news stories

    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended three medications for approval during its April meeting, and Drug development company Proniras has entered...


Go Top